Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1147
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAvanthi, A-
dc.contributor.authorJincy Mathew-
dc.contributor.authorSindhu, R-
dc.contributor.authorRintu, B-
dc.contributor.authorPandey, A-
dc.contributor.authorBinod, P-
dc.date.accessioned2014-01-23T11:30:43Z-
dc.date.available2014-01-23T11:30:43Z-
dc.date.issued2013-
dc.identifier.citationBioresource Technology 145:290–296;Oct 2013en_US
dc.identifier.urihttp://ir.niist.res.in:8080/jspui/handle/123456789/1147-
dc.description.abstractArsenic trioxide loaded biocompatible PHB–PVA1 nanoparticles (<100 nm in size) with folate functionalized surface were synthesized using poly-[(R)-3-hydroxybutyric acid] (PHB) produced by Bacillus firmus NII 0830. Folate functionalization was carried using dicyclohexyl carbodiimide (DCC) as a catalyst and 10-bromodecanol as a linker to conjugate glutamic acid terminal of folate with the hydroxylate groups present on the surface of PHBA–PVA2 nanotrojans. The effect of fabrication parameters on shape, size distribution and PDI of the PHB nanoparticles were also investigated. It was observed that increase in sonication time and polyvinyl alcohol (PVA) concentration greatly reduced the size of nanoparticles. The drug release studies on arsenic trioxide incorporated PHB–PVA nanoparticles were conducted at physiological pH and temperature. FOL–PHBA–PVA3 nanoparticles showed greater extent of cytotoxicity towards murine fibrosarcoma L929 cells than PHBA–PVA nanoparticles alone without conjugated folate, indicating the significance of folate as ligand for specific targeting of FR+ cancer cellsen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPolyhydroxybutyrateen_US
dc.subjectArsenic trioxide loadeden_US
dc.subjectpolyhydroxybutyrate–polyvinyl alcoholen_US
dc.subjectcopolymer nanoparticlesen_US
dc.subjectFolate conjugated nanoparticlesen_US
dc.subjectFolate receptor positiveen_US
dc.titleMicrobial synthesis of poly-3-hydroxybutyrate and its application as targeted drug delivery vehicleen_US
dc.typeArticleen_US
Appears in Collections:2013

Files in This Item:
File Description SizeFormat 
2013 _0104.pdf
  Restricted Access
290.83 kBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.